Therapeutic Potential for Beta-3 Adrenoreceptor Agonists in Peripheral Arterial Disease and Diabetic Foot Ulcers

Therapeutic Potential for Beta-3 Adrenoreceptor Agonists in Peripheral Arterial Disease and Diabetic Foot Ulcers

Annually, peripheral arterial disease is estimated to cost over USD 21 billion and diabetic foot disease an estimated at USD 9–13 billion. Mirabegron is a TGA-approved beta-3 adrenoreceptor agonist, shown to be safe and effective in the treatment of overactive bladder syndrome by stimulating bladder...

Full description

Bibliographic Details
Main Authors: Cameron J. F. Evans, Sarah J. Glastras, Owen Tang, Gemma A. Figtree
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Biomedicines
Subjects:
diabetes mellitus
peripheral arterial disease
wound
ulcers
oxidative stress
angiogenesis
Online Access:https://www.mdpi.com/2227-9059/11/12/3187

Internet

https://www.mdpi.com/2227-9059/11/12/3187

Similar Items